BCCIP and breast carcinoma: However, in the breast cancers that evolved from the benign lesions of BCCIP-CKD mice, BCCIP levels remained reduced, suggesting that an alternative genetic change(s) may have occurred to bypass the dependence on BCCIP for tumor progression.